What amount sold does Kineticos Disruptor Fund IB8, LLC report in Form D filings?

The latest linked filings report $5.5M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Kineticos Disruptor Fund IB8, LLC's most recent SEC filing?

Kineticos Disruptor Fund IB8, LLC's most recent Form D filing was on 2021-07-15.

How many investors does Kineticos Disruptor Fund IB8, LLC have?

The most recent Form D filing lists 20 investor(s).

What type of securities does Kineticos Disruptor Fund IB8, LLC offer?

Kineticos Disruptor Fund IB8, LLC's SEC Form D filings indicate equity offerings.

Kineticos Disruptor Fund IB8, LLC

CIK: 0001869888·Biotechnology·RALEIGH, NC·Limited Liability Company·Founded 2021

Reported Sold

$5,520,000

Total Filings

Identified Offerings

Last Filed

Jul 15, 2021

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jul 15, 2021Form D — New notice

Reported sold: $5,520,000 · Target: $18,120,000

Rule 506(b)·20 investors·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$5,520,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Nathan Finger

Related Person

Appears on 1 filing

Frank Lis

Related Person

Appears on 1 filing

Shallesh Maingi

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 15, 2021	New	$18,120,000	$5,520,000	20

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Scalpel Ventures, LLC

Biotechnology

Offering target: $10,000,000

Filed May 6, 2026